Recruiting Sarcoma Studies in Seattle
Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA)
The present study is an open-label, randomized, controlled, two-arm multi-center study of the efficacy of L19TNF treatment in combination with doxorubicin versus doxorubicin alone in metastatic leiomy...
Trial of Ixazomib for Kaposi Sarcoma
This phase II trial studies how well ixazomib works in treating patients with Kaposi sarcoma. Ixazomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth....
About Sarcoma Clinical Trials in Seattle
Sarcomas are rare cancers that arise in bone and soft tissues including muscle, fat, blood vessels, and connective tissue. There are more than 70 subtypes of sarcoma. Treatment usually involves surgery combined with radiation and/or chemotherapy.
There are currently 2 sarcoma clinical trials recruiting participants in Seattle, WASHINGTON. These studies are seeking a combined 155 participants. Research is being sponsored by Philogen S.p.A., AIDS Malignancy Consortium. Clinical trial participation is free and participants receive study-related medical care at no cost.
Sarcoma Clinical Trials in Seattle — FAQ
Are there sarcoma clinical trials in Seattle?
Yes, there are 2 sarcoma clinical trials currently recruiting in Seattle, WASHINGTON. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Seattle?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Seattle research site will contact you about next steps.
Are clinical trials in Seattle free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Seattle studies also compensate for your time and travel.
What sarcoma treatments are being tested?
The 2 active trials in Seattle are testing new therapies including novel drugs, biologics, and treatment approaches for sarcoma.
Data updated March 2, 2026 from ClinicalTrials.gov